Volitionrx Ltd (VNRX): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$983.7K
Year ended 2025-12-31
$874.5K
Trailing 12 months to 2026-06-30
+1.7%
3-year compound annual growth
+6.6%
5-year compound annual growth
+15.3%
10-year compound annual growth
$1.15M2011-12-31: $118.6K2012-12-31: $135.7K2013-12-31: $146.4K2014-12-31: $142.1K2015-12-31: $236.3K2016-12-31: $309.4K2017-12-31: $528.2K2018-12-31: $636.4K2019-12-31: $676.8K2020-12-31: $716.2K2021-12-31: $945.4K2022-12-31: $936.1K2023-12-31: $1.15M2024-12-31: $1.11M2025-12-31: $983.7K$983.7K
2011-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$983.7K-11.6%2026-03-31, From 2025-01-01
2024-12-31$1.11M-3.4%2026-03-31, From 2024-01-01
2023-12-31$1.15M+23.1%2025-03-31, From 2023-01-01
2022-12-31$936.1K-1.0%2024-03-25, From 2022-01-01
2021-12-31$945.4K+32.0%2023-03-15, From 2021-01-01
2020-12-31$716.2K+5.8%2022-03-30, From 2020-01-01
2019-12-31$676.8K+6.4%2021-03-22, From 2019-01-01
2018-12-31$636.4K+20.5%2020-02-20, From 2018-01-01
2017-12-31$528.2K+70.7%2019-03-13, From 2017-01-01
2016-12-31$309.4K+30.9%2018-03-01, From 2016-01-01
2015-12-31$236.3K+66.3%2017-03-10, From 2015-01-01
2014-12-31$142.1K-2.9%2016-03-11, From 2014-01-01
2013-12-31$146.4K+7.8%2015-03-18, From 2013-01-01
2012-12-31$135.7K+14.4%2014-03-28, From 2012-01-01
2011-12-31$118.6Kn/a2013-04-01, From 2011-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Volitionrx Ltd (VNRX)2025-12-31$983.7K-11.6%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$3.38M+6.4%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$2.19M+48.4%
Biomerica Inc (BMRA)2026-05-31$77.0K-11.5%
Aspira Women's Health Inc. (AWHL)2025-12-31$112.0K+21.7%
Immucell Corp (ICCC)2025-12-31$2.78M+2.0%
Alpha Teknova, Inc. (TKNO)2025-12-31$6.34M-3.6%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$9.77M-5.0%
Cardio Diagnostics Holdings, Inc. (CDIO)2025-12-31$65.2K+230.5%

Compare VNRX, CLDX, IMDX, BMRA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗